Gene · 10521
NIH grants1,197
NIH grants whose papers are about the gene, through NIH's grant-paper links.
601 to 620 of 1,197
Download this page as JSON| Grant | Title | DDX17 papers | Newest fiscal year |
|---|---|---|---|
| R03AG054936 | Neurogenesis in Adult Brain: Gene Networks and Alzheimer’s Disease | 1 | 2018 |
| R21AG054206 | A Novel RNA Binding Protein Modulates Tau Pathology | 1 | 2018 |
| R21AI127988 | Targeting Angiogenesis Pathways for Therapeutic Protection against Dengue | 1 | 2018 |
| R21NS100055 | Molecular mechanisms of C9orf72 and Matrin 3 interaction in ALS | 1 | 2018 |
| R21NS101661 | Drosophila models for ubiquilin-associated ALS | 1 | 2018 |
| R21OD023824 | A light-inducible protein trapping system for studying cellular dynamics in Drosophila | 1 | 2018 |
| R25CA092049 | Mayo Cancer Genetic Epidemiology Training Program | 1 | 2018 |
| R33AI116218 | Evaluating HIV expression and latency in blood and tissues at the single cell level | 1 | 2018 |
| R37AG016694 | Effectors of cellular senescence states | 1 | 2018 |
| R37GM069530 | E3-mediated Ubiquitin-like Protein Ligation | 1 | 2018 |
| R41AG060836 | Small Molecule Inhibitor Therapeutic Target for Alzheimer's Disease. | 1 | 2018 |
| R41TR002293 | Developing a novel platform for rapid identification of drug targets and anti-targets | 1 | 2018 |
| S10OD024999 | Thermo Lumos Tribrid High-Resolution Accurate-Mass Tandem Mass Spectrometer | 1 | 2018 |
| S10OD025242 | Orbitrap Fusion Lumos Mass Spectrometer for UR Proteomics Research | 1 | 2018 |
| T32AI074549 | Training Grant in Systemic Autoimmunity | 1 | 2018 |
| U01AG046161 | Discovery of Novel Proteomic Targets for Treatment of Alzheimer's Disease | 1 | 2018 |
| U19AI109725 | Autophagy Modulators as Novel Broad-Spectrum Anti-Infective Agents | 1 | 2018 |
| U54EB020403 | ENIGMA Center for Worldwide Medicine, Imaging & Genomics | 1 | 2018 |
| U54GM103368 | HIV Interactions In Viral Evolution | 1 | 2018 |
| ZICHD001421 | Characterization Of Proteins and Other Molecules By Mass Spectrometry | 1 | 2018 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10521/grants?page=31